US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 20, 2018 (8 years ago)

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations; rejected product was used to manufacture final bulk lot

What was recalled

Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2

Recalling firm
Pfizer Inc.
NDC code
59762-0541-2
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0010-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glipizide recalls

See all